Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
![](/images/homepage_main_image.png)
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is June 20, 2024.
All times in Eastern Daylight Time.
-
Airgas Sponsoring 2024 SkillsUSA National Leadership & Skills ConferenceRADNOR, Pa.--(BUSINESS WIRE)--Airgas will sponsor and supply all industrial gases used at the SkillsUSA National Leadership & Skills Conference in Atlanta from June 24–27. more »
-
QPS Announces New Global Clinical Research Operations LeadershipNEWARK, Del.--(BUSINESS WIRE)--QPS Holdings, LLC is pleased to introduce Derek Grimes, Executive Vice President and Global Head of Clinical Research. more »
-
Kennedy Mechanical and Ryan Plumbing & Heating Join NexCore, Trinity Hunt Partners’ Commercial HVAC PlatformDALLAS--(BUSINESS WIRE)--NexCore, a commercial HVAC service platform backed by Dallas-based private equity firm, Trinity Hunt Partners, is pleased to announce its partnership with Kennedy Mechanica... more »
-
PharmaEssentia Appoints Fred Paster as Head of CommercialBURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep exp... more »
-
Global Silage Additives Market Trends Analysis and Forecasts, 2023-2024 & 2029: Increasing Demand for Sustainable Silage Additives, Growing Adoption of Microbial Inoculants - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)--The "Global Silage Additives Market: Analysis By Form, By Type, By Application By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been ad... more »
-
LONDON--(BUSINESS WIRE)-- Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the “Company”) ... more »
-
Turn Therapeutics Atopic Dermatitis Candidate Reduces Disease Severity by 57% In-VivoLOS ANGELES--(BUSINESS WIRE)--Turn Therapeutics' atopic dermatitis candidate showed a dramatic reduction in disease severity versus placebo. more »
-
LONDON--(BUSINESS WIRE)-- Xtrackers II Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. L... more »
-
Financial Advisor with Over $100 Million and Nearly 30-Years of Industry Experience Joins Ameriprise Financial to Fulfill Growth AspirationsMINNEAPOLIS--(BUSINESS WIRE)--Financial advisor Michael Cruz recently joined the branch channel of Ameriprise Financial, Inc. (NYSE: AMP) from Wells Fargo Clearing Services, LLC with $100 million i... more »
-
LONDON--(BUSINESS WIRE)-- Xtrackers Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxe... more »
-
C3i Center Inc成為加拿大第一所獲得商業化生產細胞療法藥品經營許可證的委託開發暨製造服務公司蒙特婁--(BUSINESS WIRE)--(美國商業資訊)-- C3i Center Inc(以下簡稱「C3i」)宣布,該公司已通過監管核可,獲頒「藥品經營許可證」(DEL),可商業化生產細胞療法藥品。這使C3i成為加拿大第一所達成此一里程碑成就的委託開發暨製造服務 (CDMO) 公司。 C3i在通過加拿大衛生部 (Health Canada) 細胞及基因治療專家的檢驗後,獲得此核可。「藥... more »
-
C3i Center Inc é o primeiro CDMO no Canadá a receber aprovação para uma licença de estabelecimento de medicamentos para produzir comercialmente produtos farmacêuticos de terapia celularMONTREAL--(BUSINESS WIRE)--A C3i Center Inc (C3i) anunciou que recebeu aprovação regulatória, na forma de uma Licença de Estabelecimento de Medicamentos (DEL), para produzir comercialmente terapias... more »
-
C3i Center Inc是加拿大首家获得药品经营许可的委托开发制造商,可商业化生产细胞疗法药物产品蒙特利尔--(BUSINESS WIRE)--(美国商业资讯)-- C3i Center Inc (C3i) 宣布已获监管部门批准药品经营许可(DEL),可进行细胞疗法的商业化生产,从而使C3i成为加拿大首家达到这一里程碑的委托开发制造商。 在经加拿大卫生部细胞和基因治疗专家检验合格之后,C3i获批DEL,这是对该公司在专业知识、监管技术和严格质量标准方面的行业领先地位的认可。 C3i首席执... more »
-
LONDON--(BUSINESS WIRE)-- DB ETC PLC Dated: 20 June 2024 COMPANY ANNOUNCEMENT Immediate Release 20 June 2024 DB ETC plc (the Issuer) Law 1991 (as amended) with registered number 103781) Re: Issuan... more »
-
LONDON--(BUSINESS WIRE)-- DB ETC PLCs Dated: 20 June 2024 COMPANY ANNOUNCEMENT Immediate Release 20 June 2024 DB ETC plc (the Issuer) (incorporated and registered in Jersey under the Companies (Je... more »